Patient leaflet - Robitussin Chesty Cough Medicine
1. What Robitussin Chesty Cough Medicine is and what it is used for
This medicine contains the active ingredient guaifenesin. This belongs to a group of medicines called cough expectorants that work by changing an unproductive cough to a cough that is more productive and less frequent.
2. What you need to know before you take Robitussin Chesty Cough Medicine
Do not take this medicine if:
- You are allergic (hypersensitive) to guaifenesin or any of the other ingredients of this medicine (see section 6 for ingredient list).
Talk to your doctor before taking this medicine if:
- You have had a cough for a long time (such as occurs with smoking), chronic bronchitis, emphysema (disease of the lungs), if you have asthma or are suffering from an asthma attack.
Pregnancy and breastfeeding:
Please talk to your doctor before taking this medicine if you are pregnant or breastfeeding.
Important information about some of the ingredients in this medicine:
- This medicine contains sorbitol and maltitol which are sources of fructose. If you have been told by your doctor that you have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you take or receive this medicine.
This medicine contains 12.0 mg sodium benzoate in each 10 ml dose which is equivalent to
1.2 mg/ml. Sodium Benzoate may increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks old). This medicine is not for use in babies and children under 12 years.
This medicine contains 242 mg of alcohol (ethanol) in each 10 ml dose which is equivalent to 24 mg/ml (2.30% w/v). The amount in
10 ml of this medicine is equivalent to less than 6 ml beer or 3 ml wine. The amount of alcohol in this medicine will not have any noticeable effects. If you are addicted to alcohol, talk to your doctor or pharmacist before taking this medicine. The alcohol in this medicine should be taken into account if you are pregnant or breastfeeding or have liver disease or epilepsy. - This medicine contains 15.2 mg propylene glycol in each 10 ml which is equivalent to 1.5 mg/ml. Use of this medicine in newborn babies
(up to 4 weeks old) can cause harm if given with other medicines that contain propylene glycol or alcohol. This medicine should not be used in babies or children under 12 years old.
- This medicine contains 23.9 mg sodium (main component of cooking/table salt) in each 10 ml. This is equivalent to 1% of the recommended maximum daily dietary intake of sodium for an adult.
- This medicine contains 2675 mg sorbitol per 10 ml dose which is equivalent to 267.5 mg/ml. Sorbitol may cause gastrointestinal discomfort and mild laxative effect
3. How to take Robitussin Chesty Cough Medicine For oral use only.
Adults, the elderly and children over 12 years: Take 10 ml up to four times daily, as required.
Children under 12 years: Do not use.
Use the dosing cup provided with the pack.
Do not exceed the stated dose. No more than four doses should be taken in any 24 hours.
Do not take with other medicines to treat coughs or colds.
Stop using this medicine and ask a healthcare professional if you have had a cough for more than 7 days or if you have any other symptoms which might be related to your cough, for example fever, rash, persistent headache or shortness of breath.
Guaifenesin 100 mg per 5 ml Liquid for Oral Administration CHESTY COUGH
MEDICINE
If you take more medicine than you should:
If you take too much of this medicine, consult your doctor or hospital immediately.
Bring any remaining medicine with you to show the doctor.
Signs and symptoms that you have taken too much medicine are: nausea and vomiting.
If you forget to take your medicine:
Take a dose when you need to, provided the last dose was taken at least 4 hours ago.
Do not take a double dose to make up for the one you have missed.
4. Possible side effects
This medicine can cause side effects, although not everybody gets them. Side effects with guaifenesin are rare. However, some susceptible individuals may experience unwanted side effects.
If you experience any of the following side effects mentioned below or any other side effects, STOP taking this medicine immediately and contact your doctor:
- Allergic reactions. Symptoms could include itchy skin or rashes, difficulty breathing, faster heart rate, swelling of the face or throat.
Other possible side effects:
- Feeling sick (nausea) or being sick (vomiting).
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Robitussin Chesty Cough Medicine
- Do not use this medicine after the expiry date shown on the top end of the carton.
- Do not store above 25°C.
- Keep out of the sight and reach of children.
6. Contents of the pack and other information
What Robitussin Chesty Cough Medicine contains:
Each 5 ml contains 100 mg of the active substance guaifenesin.
Robitussin Chesty Cough also contains: Glycerol, Carmellose Sodium, Sodium Benzoate (E211), Sodium Cyclamate, Ethanol, Levomenthol, Maltitol (E965), Sorbitol Solution (70%), Natural Cherry Flavour, Citric Acid Anhydrous, Caramel (E150), Acesulfame Potassium, Purified Water.
Robitussin Chesty Cough Medicine is a liquid, supplied in a 100 ml bottle or 200 ml bottle.
Not all pack sizes maybe marketed.
Who makes and supplies this medicine:
The Marketing Authorisation holder for Robitussin Chesty Cough Medicine is:
Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.
The dosing cup is manufactured by:
Bormioli Pharma S.p.A. Corso Magenta, 84, 20123 Milan (MI), Italy.
This medicine is manufactured by:
Doppel Farmaceutici S.r.l., Via Martiri delle Foibe 1, 29016 Cortemaggiore (Piacenza), Italy.
If you have any queries or comments about your medicine or any other Haleon products, ring our customer Careline or e-mail us at mystory.gb@haleon.com
Trade Marks are owned by or licensed to the Haleon group of companies.
Leaflet prepared: May 2024
PL 44673/0206
0
800 7838881
30105251.002